Home Applications 205832 Application 205832
Type NDA
Sponsor BOEHRINGER INGELHEIM Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 OFEV NINTEDANIB ESYLATE CAPSULE;ORAL EQ 100MG BASE Yes No 002 OFEV NINTEDANIB ESYLATE CAPSULE;ORAL EQ 150MG BASE Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N205832-001 OFEV NINTEDANIB ESYLATE EQ 100MG BASE CAPSULE / ORAL AB RLD 2014-10-15 N205832-002 OFEV NINTEDANIB ESYLATE EQ 150MG BASE CAPSULE / ORAL AB RLD, RS 2014-10-15
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Orange Book patents# Current patent rows page 1 of 1 · 16 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N205832-001 6762180 2025-10-01 Drug substance, Drug product 2014-10-22 N205832-001 10154990 2026-01-08 U-2620 2019-09-18 N205832-001 6762180*PED 2026-04-01 Pediatric extension N205832-001 10154990*PED 2026-07-08 Pediatric extension N205832-001 10105323 2029-06-04 Drug product 2018-11-06 N205832-001 9907756 2029-06-07 Drug product 2018-04-04 N205832-001 10105323*PED 2029-12-04 Pediatric extension N205832-001 9907756*PED 2029-12-07 Pediatric extension N205832-002 6762180 2025-10-01 Drug substance, Drug product 2014-10-22 N205832-002 10154990 2026-01-08 U-2620 2019-09-18 N205832-002 6762180*PED 2026-04-01 Pediatric extension N205832-002 10154990*PED 2026-07-08 Pediatric extension N205832-002 10105323 2029-06-04 Drug product 2018-11-06 N205832-002 9907756 2029-06-07 Drug product 2018-04-04 N205832-002 10105323*PED 2029-12-04 Pediatric extension N205832-002 9907756*PED 2029-12-07 Pediatric extension
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-01 22:54:32 2026-06 N205832-001 OFEV EQ 100MG BASE CAPSULE / ORAL AB RLD 2014-10-15 a50c72e98297…2026-08-01 22:54:32 2026-06 N205832-002 OFEV EQ 150MG BASE CAPSULE / ORAL AB RLD, RS 2014-10-15 a50c72e98297…
Observed Orange Book normalized TE history# Captured, Edition, Application-product table Captured Edition Application-product TE code Order Source SHA-256 2026-08-01 22:54:32 2026-06 N205832-001 AB 1 a50c72e98297…2026-08-01 22:54:32 2026-06 N205832-002 AB 1 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-08-01 22:54:32 2026-06 N205832-001 6762180 2025-10-01 Drug substance, Drug product 2014-10-22 a50c72e98297…2026-08-01 22:54:32 2026-06 N205832-001 10154990 2026-01-08 U-2620 2019-09-18 a50c72e98297…2026-08-01 22:54:32 2026-06 N205832-001 6762180*PED 2026-04-01 Pediatric extension a50c72e98297…2026-08-01 22:54:32 2026-06 N205832-001 10154990*PED 2026-07-08 Pediatric extension a50c72e98297…2026-08-01 22:54:32 2026-06 N205832-001 10105323 2029-06-04 Drug product 2018-11-06 a50c72e98297…2026-08-01 22:54:32 2026-06 N205832-001 9907756 2029-06-07 Drug product 2018-04-04 a50c72e98297…2026-08-01 22:54:32 2026-06 N205832-001 10105323*PED 2029-12-04 Pediatric extension a50c72e98297…2026-08-01 22:54:32 2026-06 N205832-001 9907756*PED 2029-12-07 Pediatric extension a50c72e98297…2026-08-01 22:54:32 2026-06 N205832-002 6762180 2025-10-01 Drug substance, Drug product 2014-10-22 a50c72e98297…2026-08-01 22:54:32 2026-06 N205832-002 10154990 2026-01-08 U-2620 2019-09-18 a50c72e98297…2026-08-01 22:54:32 2026-06 N205832-002 6762180*PED 2026-04-01 Pediatric extension a50c72e98297…2026-08-01 22:54:32 2026-06 N205832-002 10154990*PED 2026-07-08 Pediatric extension a50c72e98297…2026-08-01 22:54:32 2026-06 N205832-002 10105323 2029-06-04 Drug product 2018-11-06 a50c72e98297…2026-08-01 22:54:32 2026-06 N205832-002 9907756 2029-06-07 Drug product 2018-04-04 a50c72e98297…2026-08-01 22:54:32 2026-06 N205832-002 10105323*PED 2029-12-04 Pediatric extension a50c72e98297…2026-08-01 22:54:32 2026-06 N205832-002 9907756*PED 2029-12-07 Pediatric extension a50c72e98297…
Observed Orange Book exclusivity history# Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2026-08-01 22:54:32 2026-06 N205832-001 ODE-261 2026-09-06 a50c72e98297…2026-08-01 22:54:32 2026-06 N205832-001 PED 2027-03-06 a50c72e98297…2026-08-01 22:54:32 2026-06 N205832-002 ODE-261 2026-09-06 a50c72e98297…2026-08-01 22:54:32 2026-06 N205832-002 PED 2027-03-06 a50c72e98297…
openFDA label cross-check# Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 12 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0597-0143 Ofev nintedanib Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0143 Ofev nintedanib Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0143 Ofev nintedanib Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0143 Ofev nintedanib Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0143 Ofev nintedanib Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0143 Ofev nintedanib Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0145 Ofev nintedanib Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0145 Ofev nintedanib Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0145 Ofev nintedanib Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0145 Ofev nintedanib Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0145 Ofev nintedanib Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current 0597-0145 Ofev nintedanib Boehringer Ingelheim Pharmaceuticals, Inc. NDA Current